Publications by authors named "Stefano Panni"

Claim this Profile
I
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses.
Francesco Schettini, Estela Pineda, Andrea Rocca, Victoria Buché, Carmine Antonio Donofrio, Stefano Panni

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Carlo Messina, Martina Catalano, Giandomenico Roviello, Annalice Gandini, Marco Maruzzo, Stefano Panni

Cancer Immunol Immunother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Stefano Panni

Cells· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Claire F Friedman, Anishka D'Souza, Diana Bello Roufai, Anna V Tinker, Maria de Miguel, Stefano Panni

Gynecol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Aristotelis Bamias, Ian D Davis, Matthew D Galsky, José Á Arranz, Eiji Kikuchi, Stefano Panni

Lancet Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report.
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D'Angelo, Stefano Panni

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Annalice Gandini, Giuseppe Fornarini, Stefano Panni

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Sara Elena Rebuzzi, Alessio Signori, Marco Stellato, Daniele Santini, Marco Maruzzo, Stefano Panni

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Umberto Basso, Federico Paolieri, Mimma Rizzo, Ugo De Giorgi, Sergio Bracarda, Stefano Panni

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Novel Three-Dimensional () Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Stefano Panni

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Matteo Brunelli, Alessandro Tafuri, Luca Cima, Maria Angela Cerruto, Michele Milella, Stefano Panni

J Clin Pathol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Marco Maruzzo, Ugo De Giorgi, Stefano Panni

Ther Adv Med Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Matthew D Galsky, José Ángel Arranz Arija, Aristotelis Bamias, Ian D Davis, Maria De Santis, Stefano Panni

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study.
Melissa Bersanelli, Sebastiano Buti, Giuseppe Luigi Banna, Ugo De Giorgi, Alessio Cortellini, Stefano Panni

Immunotherapy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Fausto Petrelli, Giulia Grizzi, Michele Ghidini, Antonio Ghidini, Margherita Ratti, Stefano Panni

J Immunother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study.
Marco Ravanelli, Giorgio Maria Agazzi, Gianluca Milanese, Elisa Roca, Mario Silva, Stefano Panni

Eur J Radiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.
Elena Verzoni, Giacomo Cartenì, Enrico Cortesi, Diana Giannarelli, Andrea De Giglio, Stefano Panni

J Immunother Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
Karim Rihawi, Diana Giannarelli, Domenico Galetta, Angelo Delmonte, Marco Giavarra, Stefano Panni

J Thorac Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Melissa Bersanelli, Diana Giannarelli, Paola Castrignanò, Giuseppe Fornarini, Stefano Panni

Immunotherapy· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.
Gianluca Tomasello, Nicola Valeri, Michele Ghidini, Elizabeth C Smyth, Wanda Liguigli, Stefano Panni, Andrea Panni

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
Matteo Brighenti, Fausto Petrelli, Sandro Barni, Barbara Conti, Enrico Sarti, Stefano Panni

Eur J Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
Rodolfo Passalacqua, Silvia Lazzarelli, Maddalena Donini, Rodolfo Montironi, Rosa Tambaro, Stefano Panni

BMC Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim.
Michele Ghidini, Jens Claus Hahne, Francesco Trevisani, Stefano Panni, Margherita Ratti

Ther Clin Risk Manag· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
Sebastiano Buti, Paola Bordi, Marcello Tiseo, Emilio Bria, Isabella Sperduti, Stefano Panni

Lung Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis